Charles River Laboratories International, Inc. SEC filings CRL
Charles River Laboratories International, Inc. has 1,005 filings in SEC EDGAR's recent list, going back to Mar 1, 2016. Its latest annual report, Form ARS, was filed on Mar 31, 2026 for the period ended Dec 27, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 26, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 27.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 26, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 27, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 28, 2026 |
| 10-Q | Quarterly report | Nov 5, 2025 | Sep 27, 2025 |
| 10-Q | Quarterly report | Aug 6, 2025 | Jun 28, 2025 |
| 10-Q | Quarterly report | May 7, 2025 | Mar 29, 2025 |
| 10-Q | Quarterly report | Nov 6, 2024 | Sep 28, 2024 |
| 10-Q | Quarterly report | Aug 7, 2024 | Jun 29, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 30, 2024 |
| 10-Q | Quarterly report | Nov 8, 2023 | Sep 30, 2023 |
| 10-Q | Quarterly report | Aug 9, 2023 | Jul 1, 2023 |
| 10-Q | Quarterly report | May 11, 2023 | Apr 1, 2023 |
| 10-Q | Quarterly report | Nov 2, 2022 | Sep 24, 2022 |
| 10-Q | Quarterly report | Aug 3, 2022 | Jun 25, 2022 |
| 10-Q | Quarterly report | May 4, 2022 | Mar 26, 2022 |
| 10-Q | Quarterly report | Nov 3, 2021 | Sep 25, 2021 |
| 10-Q | Quarterly report | Aug 4, 2021 | Jun 26, 2021 |
| 10-Q | Quarterly report | May 4, 2021 | Mar 27, 2021 |
| 10-Q | Quarterly report | Oct 29, 2020 | Sep 26, 2020 |
| 10-Q | Quarterly report | Aug 5, 2020 | Jun 27, 2020 |
| 10-Q | Quarterly report | May 7, 2020 | Mar 28, 2020 |
| 10-Q | Quarterly report | Nov 6, 2019 | Sep 28, 2019 |
| 10-Q | Quarterly report | Jul 31, 2019 | Jun 29, 2019 |
| 10-Q | Quarterly report | May 7, 2019 | Mar 30, 2019 |
| 10-Q | Quarterly report | Nov 7, 2018 | Sep 29, 2018 |
| 10-Q | Quarterly report | Aug 8, 2018 | Jun 30, 2018 |
| 10-Q | Quarterly report | May 10, 2018 | Mar 31, 2018 |
| 10-Q | Quarterly report | Nov 9, 2017 | Sep 30, 2017 |
| 10-Q | Quarterly report | Aug 9, 2017 | Jul 1, 2017 |
| 10-Q | Quarterly report | May 10, 2017 | Apr 1, 2017 |
| 10-Q | Quarterly report | Nov 2, 2016 | Sep 24, 2016 |
| 10-Q | Quarterly report | Aug 3, 2016 | Jun 25, 2016 |
| 10-Q | Quarterly report | May 4, 2016 | Mar 26, 2016 |
Showing 33 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Commercial Physical & Biological Research (SIC 8731)
- Listed as
- CRL (NYSE)
- Fiscal year ends
- December 27
- Headquarters
- Wilmington, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1100682
- Former names
- CHARLES RIVER LABORATORIES INTERNATIONAL INC (until May 30, 2019); CHARLES RIVER LABORATORIES HOLDINGS INC (until Jan 28, 2000)
Other Services-Commercial Physical & Biological Research companies
- Iqvia Holdings Inc. IQV
- Incyte Corp INCY
- Medpace Holdings, Inc. MEDP
- Icon PLC ICLR
- Absci Corp ABSI
- OmniAb, Inc. OABI
- NRC Health NRC
- Maxcyte, Inc. MXCT
All 17 Services-Commercial Physical & Biological Research companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.